Renal biomarker market to reach US$ 1,770 Mn by 2026

New market report from Future Market Insights

December 2016

“A new market report from Future Market Insights: “Renal Biomarker Market: Global Industry Analysis and Opportunity Assessment, 2016–2026” is projecting, in terms of revenue, that the global renal biomarker market is to register a healthy CAGR of 7.0% over the forecast period – to reach a total of US$ 1,770 Mn at the end of the period.


The projections strongly backs up the focused strategy from BioPorto Diagnostics in working closely with the FDA in order to send in a new FDA submission for our structural renal biomarker – The NGAL Test - and at the same time continue with intensified sales focus in Europe and South Korea”


See further at: